Concluding Remarks and the Future of Nanotheranostics

Abstract

The year 2018 is predicted to have more than 1.7 million cases of cancer diagnosed with approximately 609,640 mortalities resulting in equivocating 1700 deaths per day [1]. Of these cancers diagnosed, the most fatal and prevalent are lung, prostate, and colorectal in men and breast, lung, and colorectal cancer in women [1]. Prostate cancer will account for 20% of the oncologic disease incidence in men, while breast cancer will account for 63,960 cases in women [1]. The daily diagnoses of 4700 affected individuals render this type of pathology prominent and in dire need of finding more ways to effectively diagnose and treat patients, thus reducing the mortality associated with these various types of cancer [1]. A summary hereto to elaborate and reflect upon these efforts to improve the lives of patients and the rationale behind such attempts to further improve on detection and diagnosis and effectively treat cancer pathologies are discussed as we conclude this book.